SRP309079 PRJNA706355 GSE168144 Colorectal liver metastases-specific lncRNA CRLM1 inhibits apoptosis and promotes metastasis through transcriptional regulation cooperated with hnRNPK [CRLM1_CHIRP] The survival rate of colorectal liver metastases remains low. Long noncoding lncRNAs is emerging as a novel class of master regulators of cell invasion and metastasis. In this study, analysis of the lncRNA expression dynamics in the colorectal liver metastases, primary colorectal tumor and normal tissues led to the identification of the metastasis-specific expression of a set of lncRNAs including CRLM1. CRLM1 inhibited apoptosis and promoted metastasis and invasion of colorectal cancer cells, and also promoted tumor growth in nude mice. CRLM1 weakly associated with chromatin regions of genes involved in cell adhesion and DNA damage, correlated with CRLM1-regulated gene expression bidirectionally. CRLM1 physically interacts with and promotes the nuclear localization of the metastasis protein hnRNPK. CRLM1 effectively promotes hnRNPK promoter occupancy, and co-regulate gene expression. These findings suggest a potential biomarker and druggable target for treatment of colorectal liver metastases. Overall design: To decipher how lncRNA-CRLM1 regulates gene expression in HCT116 cells, Chromatin Isolation by RNA Purification (ChIRP) method was performed to identify the potential CRLM1-chromatin interaction sites by sequencing the CRLM1 associated chromatin DNA fragments (ChIRP-seq). Anti-LacZ and Input samples were used as control. Two biological replicates were obtained for each sample. GSE168144 pubmed 35907898 parent_bioproject PRJNA706350